Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Early Loop-Diuretic Administration and Subsequent Kidney Deterioration in Hospitalized Patients with Heart Failure: A MIMIC-IV Landmark Study.

Created on 18 Nov 2026

Authors

Batool Mrayyan, Mustafa Salaho

Published in

Journal of cardiovascular pharmacology. Nov 17, 2026. Epub Nov 17, 2026.

Abstract

Early loop diuretics are central to decongestion in heart failure, but their association with subsequent kidney deterioration remains uncertain. We conducted a retrospective 6-hour landmark study of adults with ICD-coded heart failure in MIMIC-IV. Exposure was documented administration of furosemide, bumetanide, or torsemide before 6 hours. Eligible admissions required baseline creatinine and a follow-up measurement from 6 to <48 hours. Kidney deterioration was defined as a creatinine increase of ≥0.3 mg/dL or ≥1.5-fold from baseline. We estimated crude and adjusted associations using propensity-score weighting and augmented inverse probability weighting (AIPW); adjusted and weighted confidence intervals accounted for repeated admissions by patient, whereas the crude interval did not. Among 23,336 admissions from 15,764 patients, 2,453 (10.5%) received early treatment and 4,506 (19.3%) met the endpoint. Kidney deterioration occurred in 22.7% of early-treated admissions versus 18.9% of comparators (crude risk ratio [RR] 1.20, 95% CI 1.11-1.30). The directly adjusted RR was 1.30 (95% CI 1.20-1.41), the overlap-weighted RR was 1.31 (95% CI 1.21-1.43), and the AIPW RR was 1.31 (95% CI 1.20-1.44). The overlap-weighted absolute risk difference was 5.5 percentage points (95% CI 3.7-7.4). Mortality was not significantly associated with early treatment (RR 1.12, 95% CI 0.96-1.30). Restricting the endpoint to the first follow-up creatinine attenuated the association (overlap-weighted RR 1.01, 95% CI 0.87-1.17), highlighting sensitivity to monitoring intensity. Early loop-diuretic administration was associated with higher subsequent creatinine-defined deterioration, but differential surveillance and confounding by indication preclude causal conclusions or recommendations to delay treatment.

PMID:
43044035
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement